Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
-
Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
-
Worldplay Inc. (WP) PT Raised to $92 at Cantor Fitzgerald
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $202 at Cantor Fitzgerald
-
Supernus Pharmaceuticals (SUPN) PT Raised to $52 at Cantor Fitzgerald
-
Health Insurance Innovations (HIIQ) PT Raised to $60 at Cantor Fitzgerald, 'Fundamentals Accelerating'
-
Physicians Realty Trust (DOC) PT Lowered to $18 at Cantor Fitzgerald
-
Aerie Pharma (AERI) PT Raised to $86 at Cantor Fitzgerald
-
Glaukos Corporation (GKOS) PT Lowered to $43 at Cantor Fitzgerald; 'Investment and Not Growth, for Now'
-
Moody's Corp (MCO) PT Raised to $171 at Cantor Fitzgerald
-
Xencor, Inc. (XNCR) PT Raised to $37 at Cantor Fitzgerald
-
Corium Internation (CORI) Plans Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
-
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
-
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
-
Mudrick Capital Acquisition Corporation Announces Closing of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering
-
Cantor Fitzgerald Investors, LLC Closes on a $40 Million Class A Office Building
-
Cantor Fitzgerald Tops 2017 At-the-Market Offering (ATM) League Table
-
Pre-Open Movers 02/28: (PHH) (AAXN) (ETSY) Higher; (FTR) (TSRO) (CELG) Lower (more...)
-
Riot Blockchain (RIOT) Names Rob Chang as CFO
-
Riot Blockchain Appoints Rob Chang as Chief Financial Officer
-
MannKind (MNKD) Enters $50M ATM Offering with Cantor Fitzgerald
-
Rosetta Genomics (ROSG) Reports Agreement to Sell Business to Genoptix for $9M in Cash
-
Square (SQ) PT Raised to $51 at Cantor Fitzgerald
-
Global Blood Therapeutics (GBT) PT Raised to $72 at Cantor Fitzgerald
-
Teladoc (TDOC) PT Raised to $35 at Cantor Fitzgerald
-
Envision Healthcare (EVHC) PT Raised to $40 at Cantor Fitzgerald
-
Genoptix Enters into New Agreements to Acquire Rosetta Genomics for $9 Million in Cash
-
280 CapMarkets Expands Its Corporate Bond Trading Capabilities and Institutional Sales Team
-
Aimmune Therapeutics Announces Closing of Public Offering of Common Stock
-
Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares
-
HMS Holdings (HMSY) PT Raised to $17 at Cantor Fitzgerald;'4Q17 Bounce Back but 2018 Guidance is Light'
-
Lifepoint Holdings (LPNT) PT Lowered to $45 at Cantor Fitzgerald; 'Weak Volumes, Bad Debt Hurt 4Q17'
-
Tivity Health (TVTY) PT Raised to $53 at Cantor Fitzgerald
-
Sabra Healthcare REIT Inc. (SBRA) PT Lowered to $25 at Cantor Fitzgerald
-
Freddie Mac Prices $1.1 Billion Multifamily K-Deal, K-F43
-
MedEquities Realty Trust (MRT) PT Lowered to $13 at Cantor Fitzgerald Citing Recent Surge in Interest Rates
-
HealthStream (HSTM) PT Raised to $25 at Cantor Fitzgerald
-
Verisk Analytics (VRSK) PT Raised to $112 at Cantor Fitzgerald, 'Organic Growth Back to Historical Norms"
-
Aimmune Therapeutics (AIMT) Prices 5.5M Share Common Offering at $32/Sh
-
UDR, Inc. (UDR) PT Lowered to $40 at Cantor Fitzgerald
-
Essex Property Trust (ESS) PT Lowered to $264 at Cantor Fitzgerald
-
bluebird bio (BLUE) PT Raised to $122 at Cantor Fitzgerald
-
Aimmune Therapeutics Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Aduro Biotech (ADRO) at Overweight, 'Leading Edge of I/O'
-
Spring Bank Pharmaceuticals (SBPH) PT Raised to $32 at Cantor Fitzgerald
-
EPAM Systems (EPAM): Strong Fundamentals And Technicals - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight on PolarityTE (COOL)
-
Aimmune Therapeutics (AIMT) Offers $150M in Common Equity
-
Aimmune Therapeutics Announces Proposed Public Offering of Common Stock
-
Alkermes (ALKS) PT Lowered to $50 at Cantor Fitzgerald

